Wockhardt tanks 20% on US FDA import alert

The US drug regulator has issued an import alert on Wockhardt's facility at Aurangabad in Maharashtra. The stock closed down 20 percent, its lower circuit level, at Rs 1,313.80 on NSE.
  • Language
  • App
  • Subscriptions
  • Specials
  • Sign-In
  • Register
Real-time Stock quotes, portfolio, LIVE TV and more.
GeStepAhead SME Special
moneycontrol.com

Home » News » Business

May 24, 2013, 10.48 AM | Source: Moneycontrol.com

Wockhardt tanks 20% on US FDA import alert

The US drug regulator has issued an import alert on Wockhardt's facility at Aurangabad in Maharashtra. The stock closed down 20 percent, its lower circuit level, at Rs 1,313.80 on NSE.

Like this story, share it with millions of investors on M3

Wockhardt tanks 20% on US FDA import alert

The US drug regulator has issued an import alert on Wockhardt's facility at Aurangabad in Maharashtra. The stock closed down 20 percent, its lower circuit level, at Rs 1,313.80 on NSE.

Post Your Comments

Share Cancel

Moneycontrol Bureau

Shares of Mumbai-based Wockhardt slumped 20 percent on Thursday after the US Food and Drugs Administration issued an import alert on one of the pharma company's manufacturing facility at Aurangabad in Maharashtra.

The import alert posted on FDA website is dated May 22, 2013.

An import alert means detention of drugs without physical examination from firms, which have not complied with current good manufacturing practises, the drug regulator states.

The US FDA had issued a 483 form through a routine course of inspection of one of its facilities in Aurangabad in April. A form 483 is issued when the FDA observes any violation from standard manufacturing practices.

Wockhardt Chairman Habil Khorakiwala confirmed that the FDA had put an import alert on one of its facilities.

"We estimate that it would impact our business by USD 100 million on an annualised basis," he told PTI.

He further informed the news agency that the company won't be able to export products to the US from the facility, which makes injectables as well as solid dosages. The production will be shifted to a nearby facility to minimise the impact, he added.

Wockhardt shares closed down 20 percent (lower circuit limit) at Rs 1,313.80 on NSE. The stock more than trebled in financial year 2013. Since April 1, however, the stock has corrected 34.5 percent.

Also Read: Ranbaxy plunges 10% on reports Indian govt orders probe

 

Ads by Google

Buy, Hold, Sell ? Hear it first on M3
Wockhardt tanks 20% on US FDA import alert

See all

Get started using your favorite social network

or

Login using moneycontrol ID

Username
Password

Need help logging in? Reset password.

Don´t have an account? Sign Up

Get started using your favorite social network

or

Simply sign up using this short form

* mandatory

UserName*

Username should be atleast 4 character

Password*

Password should be 8 or more characters,
atleast 1 number, 1 symbol & 1 upper case letter

Alert

Your Password should contain
  • 8 or more characters
  • At least 1 number
  • At least 1 symbol
  • At least 1 upper case letter
Confirm Password*
Email
Already have an account? Login